AMZN
Amazon.com, Inc.
AMZN has the edge over SON overall, supported by stronger modeled upside and stronger valuation.
SON
Sonoco Products Company
SON trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SON Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
SON's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
SON PE Valuation
SON has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over SON on the outlook, with more favorable earnings and revenue expectations.
SON Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect SON's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SON on earnings quality, reporting a profit while its opponent remains loss making.
SON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.61 | — |
| Q3 2026 | -$2.30 | -137% |
| Q2 2026 | $6.29 | +13% |
| Q1 2026 | $10.20 | +562% |
| Q4 2025 | $10.07 | +510% |
| Q3 2025 | $6.30 | +116% |
| Q2 2025 | $5.58 | +50% |
| Q1 2025 | $1.54 | -61% |
| Q4 2024 | $1.65 | -66% |
SON has swung to a loss: it lost $2.30 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over SON on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over SON on profitability, with a higher operating margin.
SON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | -4.2% |
| Q2 2026 | $1.9B | -1.3% |
| Q1 2026 | $1.7B | -1.9% |
| Q4 2025 | $1.8B | +30% |
| Q3 2025 | $2.1B | +27% |
| Q2 2025 | $1.9B | +18% |
| Q1 2025 | $1.7B | +4.4% |
| Q4 2024 | $1.4B | -17% |
SON's revenue has held roughly level: $2B last quarter, down 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -31% | -40 points |
| Q2 2026 | 10% | +1 points |
| Q1 2026 | 7.6% | +0.2 points |
| Q4 2025 | 29% | +33 points |
| Q3 2025 | 9.2% | +1.5 points |
| Q2 2025 | 9.2% | +0.5 points |
| Q1 2025 | 7.4% | +0.5 points |
| Q4 2024 | -4% | -12 points |
SON's operating margin was −31% last quarter, down 40 points from the same quarter a year ago, near the bottom of its range since 2019.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $221.9M | -1.6% |
| Q2 2026 | $236.9M | +140% |
| Q1 2026 | -$430M | -$129.3M |
| Q4 2025 | $322.3M | +17% |
| Q3 2025 | $225.6M | +220% |
| Q2 2025 | $98.6M | +516% |
| Q1 2025 | -$300.8M | -477% |
| Q4 2024 | $274.3M | +74% |
SON has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
SON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -279K shares |
| 1 year | -0.1% | -146K shares |
| 3 years | +0.6% | +590K shares |
| 5 years | +0.1% | +77K shares |
| Available history | -1.7% | -1.7M shares |
SON has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $181,000 |
| Q2 2026 | $57,000 |
| Q1 2026 | $7M |
| Q4 2025 | $350,000 |
| Q3 2025 | $4,000 |
| Q2 2025 | $3,000 |
| Q1 2025 | $10.6M |
| Q4 2024 | $74,000 |
SON spent $8M buying back its own shares over the past year, down 29% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over SON on leverage, with a lower net debt burden relative to earnings.
SON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 5.3x | High |
| Q2 2025 | 6.2x | High |
| Q1 2025 | 9.3x | High |
| Q4 2024 | 9.4x | High |
SON's net debt is about 5.6 years of its operating earnings (EBITDA), up from 5.3 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 22.6 | Neutral |
SON's weekly RSI is 44 (neutral) and its Stochastic is 23 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
SON PE vs Consumer Cyclical Sector
| Metric | SON | Sector median | Relative |
|---|---|---|---|
| PE | 7.9x | 18x | 56% below |
| PE % | 15 | 47 | 32 pts below |
SON has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over SON on trend strength, trading above more of its moving averages.
SON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $49.5 | 1.6% below |
| 20 week MA | $53.1 | 8.2% below |
| 50 week MA | $51.3 | 5% below |
| 100 week MA | $48.3 | 0.9% above |
| 200 week MA | $52.3 | 6.8% below |
SON's trend is mixed: it's above one of its five weekly moving averages, and 6.8% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over SON on returns for 2026, with the stronger performance.
SON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.3 | $59.4 | -3.1% |
| 2021 | $59.4 | $55.5 | -6.6% |
| 2022 | $55.5 | $60.4 | +8.9% |
| 2023 | $60.4 | $55.9 | -7.5% |
| 2024 | $55.9 | $48.9 | -12% |
| 2025 | $48.9 | $43.5 | -11% |
| 2026 YTD | $43.5 | $48.7 | +12% |
SON has finished three years in a row lower, and it's up 12% so far in 2026.